The clinical utility index as a practical multiattribute approach to drug development decisions

Area of Science:

• Drug development
• Decision analysis
• Clinical pharmacology

Background:

• Early-stage drug development requires robust methods for predicting patient benefit.
• Existing decision-making tools may not adequately capture clinical utility in early phases.
• Financial factors are often less critical than clinical attributes in early drug development.

Purpose of the Study:

• To identify innovative approaches for predicting patient benefit from investigational drugs.
• To introduce and illustrate the calculation of a probabilistic Clinical Utility Index (CUI).
• To recommend the CUI for supporting early-phase drug development decisions.

Main Methods:

• Development of a multiattribute utility framework focusing on clinical attributes.
• Calculation of a probabilistic Clinical Utility Index (CUI).
• Evaluation of the CUI's practicality, accuracy, and transparency.

Main Results:

• The study proposes innovative approaches for predicting patient benefit.
• A probabilistic Clinical Utility Index (CUI) was successfully calculated.
• The CUI demonstrates practicality, reasonable accuracy, and transparency.

Conclusions:

• The Clinical Utility Index (CUI) is recommended for early drug development decisions.
• The CUI effectively supports decision-making by focusing on clinical attributes.
• The CUI offers a transparent and practical tool for assessing investigational drugs.